More Atomo Diagnostics Ltd. news
Atomo Diagnostics Ltd.ASX: AT1

Atomo and Access Bio renegotiate supply agreements

Oct 5, 2021 at 12:03 AM EDT · Issued by Atomo Diagnostics Ltd.

Filed with ASX · Oct 5, 2021 at 12:03 AM EDT

On 6ix: 6ix.com/news/atomo-and-access-bio-renegotiate-supply-agreements

Atomo Diagnostics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Atomo Diagnostics Ltd. on 6ix

Story so far

  • Access Bio receives FDA clearance for COVID-19 antibody testJun 28, 2021
  • Atomo & Access Bio sign deal for rapid antigen testSep 29, 2020
  • Atomo & Access Bio enter North American COVID-19 partnershipJul 28, 2020

Earlier from Atomo Diagnostics

  • FY21 Results PresentationAug 27, 2021
  • Appendix 4E & Annual Financial ReportAug 27, 2021
  • Quarterly Activity Report - 30 June 2021Jul 28, 2021
  • Appendix 4C - 30 June 2021Jul 28, 2021
  • Access Bio receives FDA clearance for COVID-19 antibody testJun 27, 2021

Later from Atomo Diagnostics

  • Appendix 4C - 30 September 2021Oct 25, 2021
  • Quarterly Activity Report - 30 September 2021Oct 25, 2021
  • HIV Self-Test - improved supply & advertising conditionsOct 25, 2021
  • Appendix 4C - 31 December 2021Jan 24, 2022
  • Quarterly Activity Report - 31 December 2021Jan 24, 2022
All Atomo Diagnostics news releases↗

Follow Atomo Diagnostics into a list and get an email when it puts out news.

Follow Atomo Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer